Pacira BioSciences, Inc. PCRX Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Pacira BioSciences, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s free cash flow yield?
- Pacira BioSciences, Inc. (PCRX) reported free cash flow yield of 14.5% in Q1 2026.
- How has Pacira BioSciences, Inc.'s free cash flow yield changed year-over-year?
- Pacira BioSciences, Inc.'s free cash flow yield increased by 4.6% year-over-year, from 13.9% to 14.5%.
- What is the long-term trend for Pacira BioSciences, Inc.'s free cash flow yield?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s free cash flow yield has grown at a 52.8% compound annual growth rate (CAGR), from 1.5% to 12.3%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.